Emtricitabine
Emtricitabine is a potent nucleoside reverse transcriptase inhibitor (NRTI) effective against HIV and HBV, demonstrating an EC50 of 0.01 μM in PBMC assays. It is widely used in both in vitro virology studies and in vivo models to investigate antiviral mechanisms and therapeutic strategies for retroviral infections.
Product Specifications
CAS Number
143491-57-0
Product Name Alternative
ReverseTranscriptase, Reverse Transcriptase, BW 1592, BW1592, BW-1592, Inhibitor, inhibit, Human immunodeficiency virus, HIVProtease, HIV Protease, HIV, Emtricitabine, Emtriva, FTC
Field of Research
Infectious Disease & Virology, Metabolism Research, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.15% (May vary between batches)
Solubility
DMSO:237 mg/mL (958.54 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (20.22 mM)
Smiles
Nc1nc (=O) n (cc1F) [C@@H]1CS[C@H] (CO) O1
Molecular Formula
C8H10FN3O3S
Molecular Weight
247.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1091783-01 250 mg
(3-chloro-5- (cyclopropylmethoxy) phenyl) boronic acid
Sign In for Pricing
View Details OR1091783-02 500 mg
(3-chloro-5- (cyclopropylmethoxy) phenyl) boronic acid
Sign In for Pricing
View Details OR1091783-03 1 g
(3-chloro-5- (cyclopropylmethoxy) phenyl) boronic acid
Sign In for Pricing
View Details